Paul Spence

SVP, U.S. Pharmaceuticals at Aimmune Therapeutics

Paul Spence has more than 28 years in the healthcare and pharmaceutical market. His highly successful foundation was built upon US and Global roles in marketing, sales, operations, strategy, and commercial leadership sharing his passion for building new teams, launching new models and brands, and leading organizational transformation. Culture and talent development are very important to Paul and central to his approach to leading his teams and partnering cross-functionally. He joined Nestlé Health Science (NHSc) 4 years ago as the Vice President of Medical Nutrition Sales where he transformed his Sales Leadership Team with fast-paced growth initiatives and new GTM models. Most recently he was the Business Executive Officer for NHSc US Pharmaceuticals, leading the integration of Zenpep and Viokace, and developing the NHSc US Pharmaceutical organization and operations across all operating functions in the US and globally.

Previous to NHSc he was with Boehringer-Ingelheim (BI), culminating with the position of Vice President of Sales, South Area. Prior to that he was Executive Director of the Go-to-Market model where he led BI’s national initiative to transform the US medical and commercial customer-facing model to support BI’s long-range forecast, portfolio evolution and marketplace change. Before joining BI, Paul spent 6 years with Sanofi-Aventis where he held several commercial roles to include the build and launch of the Quality Initiatives Organization. His other experience includes marketing, field leadership, and operations roles with Bristol-Myers Squibb and Johnson & Johnson.

Paul earned a BS in finance and accounting from The Pennsylvania State University and an MBA from Villanova University. He also holds several certifications including Six Sigma Green Belt and Loyola University Quality Institute.

Timeline

  • SVP, U.S. Pharmaceuticals

    Current role

View in org chart